Bitget Lists Four New Stock Perpetuals
Bitget has expanded its trading products by listing four new stock perpetual pairs, including USDESTOCKUSDT, VKTXUSDT, PCVXUSDT, and XPUSDT.
Cryptocurrency derivatives exchange Bitget has announced the addition of four new stock perpetual trading pairs to its platform. According to Bitget_Announcements, the new pairs—USDESTOCKUSDT, VKTXUSDT, PCVXUSDT, and XPUSDT—went live on October 6, 2026, at UTC+8. The expansion is aimed at enriching the exchange's trading offerings and meeting the diverse investment needs of its users.
Included Assets and Background
Instant Telegram notifications for large on-chain moves.
The newly listed perpetual contracts cover a range of entities from stablecoin infrastructure to biopharmaceuticals and financial platforms. USDESTOCK represents StablecoinX Inc., a stablecoin infrastructure company focused on the Ethena ecosystem that listed on Nasdaq in June 2026 via a SPAC merger. Its core assets include approximately 3.03 billion Ethena governance tokens (ENA), valued at roughly $275 million at closing.
Other listed assets include Viking Therapeutics (VKTX), a clinical-stage biopharmaceutical company developing metabolic disorder therapies; Vaxcyte (PCVX), a clinical-stage vaccine developer focused on pneumococcal conjugate vaccines; and XP Inc. (XP), an independent investment platform based in Brazil.
Risk Management and Leverage
Bitget noted that parameters such as leverage and margin ratios may be adjusted based on prevailing market conditions. The exchange also reminded traders that stock index perpetuals can experience high volatility and that trading with high leverage significantly increases risk exposure.
Key facts
- Bitget listed USDESTOCKUSDT, VKTXUSDT, PCVXUSDT, and XPUSDT stock perps on October 6, 2026 (UTC+8).
- USDESTOCK is the ticker for StablecoinX Inc., holding approximately 3.03 billion Ethena governance tokens valued at $275 million at closing.
- VKTX represents Viking Therapeutics, a biopharmaceutical firm developing the VK2735 obesity treatment candidate.
- PCVX corresponds to Vaxcyte, focusing on pneumococcal conjugate vaccines such as VAX-24 and VAX-31.
- XP Inc. operates an open product platform providing securities brokerage and wealth management services in Brazil.
Source: bitget.com
This article is for information only and is not investment advice. BullishMarketCap news is produced with AI assistance from public sources and reviewed by our editors; see our editorial policy. Spotted an error? Tell us.
